SFG
IRWD icon

Steward Financial Group’s Ironwood Pharmaceuticals IRWD Stock Holding History

Steward Financial Group’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$0 Buy
+17
New +$167 ﹤0.01% 1432
2023
Q2 		– Sell
-109
Closed -$1K – 727
2023
Q1 		$1K Buy
109
+80
+276% +$896 ﹤0.01% 621
2022
Q4 		$0 Buy
+29
New +$329 ﹤0.01% 672
2022
Q3 		– Sell
-65
Closed – – 684
2022
Q2 		$0 Buy
+65
New +$766 ﹤0.01% 1156

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Steward Financial Group's IRWD Position: Q3 2023 in Review

Steward Financial Group opened a new position in Ironwood Pharmaceuticals (IRWD) in Q3 2023: 17 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #1432 among its holdings. This is a return to the name: Steward Financial Group previously reported a position in IRWD as recently as Q1 2023.

Steward Financial Group first reported a position in IRWD in Q2 2022 and has held it in 4 quarters since. The position peaked at $1K in Q1 2023. 248 funds tracked by Wall St. Rank hold IRWD as of Q3 2023.

  • Steward Financial Group held 17 shares of Ironwood Pharmaceuticals worth $0 as of Q3 2023.
  • Ironwood Pharmaceuticals was a new Steward Financial Group position in Q3 2023.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Steward Financial Group's portfolio in Q3 2023, its #1432 holding.
  • Steward Financial Group first reported a position in Ironwood Pharmaceuticals in Q2 2022 and has held it in 4 quarters since.
  • Steward Financial Group's Ironwood Pharmaceuticals position peaked at $1K in Q1 2023.
  • 248 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2023.

Based on Steward Financial Group's 13F filing for Q3 2023, filed 23 Oct 2023.